BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12135353)

  • 1. Transmembrane interactions in the activation of the Neu receptor tyrosine kinase.
    Smith SO; Smith C; Shekar S; Peersen O; Ziliox M; Aimoto S
    Biochemistry; 2002 Jul; 41(30):9321-32. PubMed ID: 12135353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimer interface of transmembrane domains for neu/erbB-2 receptor dimerization and transforming activation: a model revealed by molecular dynamics simulations.
    Sajot N; Genest M
    J Biomol Struct Dyn; 2001 Aug; 19(1):15-31. PubMed ID: 11565846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erbB-2 receptor.
    Smith SO; Smith CS; Bormann BJ
    Nat Struct Biol; 1996 Mar; 3(3):252-8. PubMed ID: 8605627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Val(659)-->Glu mutation within the transmembrane domain of ErbB-2: effects measured by (2)H NMR in fluid phospholipid bilayers.
    Sharpe S; Barber KR; Grant CW
    Biochemistry; 2000 May; 39(21):6572-80. PubMed ID: 10828974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of threonine hydrogen bonding in the glycophorin A transmembrane helix dimer.
    Smith SO; Eilers M; Song D; Crocker E; Ying W; Groesbeek M; Metz G; Ziliox M; Aimoto S
    Biophys J; 2002 May; 82(5):2476-86. PubMed ID: 11964235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure prediction of the dimeric neu/ErbB-2 transmembrane domain from multi-nanosecond molecular dynamics simulations.
    Sajot N; Genest M
    Eur Biophys J; 2000; 28(8):648-62. PubMed ID: 10663532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane helix packing of ErbB/Neu receptor in membrane environment: a molecular dynamics study.
    Aller P; Garnier N; Genest M
    J Biomol Struct Dyn; 2006 Dec; 24(3):209-28. PubMed ID: 17054379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation.
    Burke CL; Lemmon MA; Coren BA; Engelman DM; Stern DF
    Oncogene; 1997 Feb; 14(6):687-96. PubMed ID: 9038376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane peptides from tyrosine kinase receptor. Mutation-related behavior in a lipid bilayer investigated by molecular dynamics simulations.
    Samna Soumana O; Aller P; Garnier N; Genest M
    J Biomol Struct Dyn; 2005 Aug; 23(1):91-100. PubMed ID: 15918680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmembrane domain sequence requirements for activation of the p185c-neu receptor tyrosine kinase.
    Chen LI; Webster MK; Meyer AN; Donoghue DJ
    J Cell Biol; 1997 May; 137(3):619-31. PubMed ID: 9151669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of proto-oncogenic and mutant forms of the transmembrane region of the Neu receptor in TFE.
    Houliston RS; Hodges RS; Sharom FJ; Davis JH
    FEBS Lett; 2003 Jan; 535(1-3):39-43. PubMed ID: 12560075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics (MD) investigations of preformed structures of the transmembrane domain of the oncogenic Neu receptor dimer in a DMPC bilayer.
    Aller P; Voiry L; Garnier N; Genest M
    Biopolymers; 2005 Mar; 77(4):184-97. PubMed ID: 15660449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane helix orientation influences membrane binding of the intracellular juxtamembrane domain in Neu receptor peptides.
    Matsushita C; Tamagaki H; Miyazawa Y; Aimoto S; Smith SO; Sato T
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1646-51. PubMed ID: 23319611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling of c-erbB2 receptor dimerization: coiled-coil structure of wild and oncogenic transmembrane domains--stabilization by interhelical hydrogen bonds in the oncogenic form.
    Garnier N; Genest D; Duneau JP; Genest M
    Biopolymers; 1997 Aug; 42(2):157-68. PubMed ID: 9234995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface.
    Burke CL; Stern DF
    Mol Cell Biol; 1998 Sep; 18(9):5371-9. PubMed ID: 9710621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the oncogenic V(664)E mutation on membrane insertion, structure, and sequence-dependent interactions of the Neu transmembrane domain in micelles and model membranes: an integrated biophysical and simulation study.
    Beevers AJ; Nash A; Salazar-Cancino M; Scott DJ; Notman R; Dixon AM
    Biochemistry; 2012 Mar; 51(12):2558-68. PubMed ID: 22385253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase.
    Bell CA; Tynan JA; Hart KC; Meyer AN; Robertson SC; Donoghue DJ
    Mol Biol Cell; 2000 Oct; 11(10):3589-99. PubMed ID: 11029057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence dependence of BNIP3 transmembrane domain dimerization implicates side-chain hydrogen bonding and a tandem GxxxG motif in specific helix-helix interactions.
    Sulistijo ES; MacKenzie KR
    J Mol Biol; 2006 Dec; 364(5):974-90. PubMed ID: 17049556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Transmembrane Domain Interactions in Neu Receptor Tyrosine Kinase by Membrane Fluidity and Cholesterol.
    Hasan M; Patel D; Ellis N; Brown SP; Lewandowski JR; Dixon AM
    J Membr Biol; 2019 Oct; 252(4-5):357-369. PubMed ID: 31222471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural implications of a Val-->Glu mutation in transmembrane peptides from the EGF receptor.
    Sharpe S; Grant CW; Barber KR; Giusti J; Morrow MR
    Biophys J; 2001 Dec; 81(6):3231-9. PubMed ID: 11720988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.